This campaign is organised and funded by Astellas Pharma Europe Ltd.
This campaign is organised and funded by Astellas Pharma Europe Ltd.
Let's talk prostate cancer - Digital Atlas
astellas lets talk
Let's talk prostate cancer - Digital Atlas
astellas lets talk

Let's talk prostate cancer
Digital Atlas
astellas lets talk
HOME ABOUT INCIDENCE MORTALITY SURVIVAL PROSTATE CANCER CARE QoL POLICIES GUIDELINES PATIENT STORIES LTPC CAMPAIGN RESOURCES CONTACT
HOME ABOUT INCIDENCE MORTALITY SURVIVAL PROSTATE CANCER CARE QoL POLICIES GUIDELINES PATIENT STORIES LTPC CAMPAIGN RESOURCES CONTACT PRIVACY NOTICE COOKIES
Page top is here
blank

Prostate cancer can have a severe impact on those affected and their families.1 This impact manifests itself not only in terms of mortality and survival but also in relation to the daily quality of life (QoL) of patients.2,3 This can include impact on the urinary, sexual and bowel function as well as on energy and performance in physical and social roles.3

Prostate cancer treatment at metastatic phase can have a negative effect on quality of life. Ensuring early detection and diagnosis is therefore vital for enabling those affected to live with a better quality of life.4

A patient survey carried out by EuropaUomo provides a snapshot of the impact on quality of life for men with prostate cancer across Europe.5

The survey shows that urinary incontinence and sexual dysfunction were the two areas where men reported the lowest quality of life scores.5

The results indicate that the best quality of life scores are seen where the cancer is discovered at an early stage.5 Efforts should therefore be made to ensure early detection and awareness to avoid unnecessary deterioration in quality of life.

To access the complete survey results, please access EuropaUomo's presentation here.

 

1 Orchid. More to do, Identifying and tackling the unmet need in prostate cancer care. 2015. Accessible at https://orchid-cancer.org.uk/wp-content/uploads/2016/02/Prostate-Cancer-More-to-do-Report-FINAL.pdf (last accessed September 2020)
2 Ferlay, J et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer. 2018; 103:356-387
3 Eton, DT. Prostate Cancer and health-related Quality of Life. 2008. Accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2593110/pdf/nihms-79523.pdf (last accessed September 2020)
4 Van Poppel, H et al. Policy Paper on PSA Screening for Prostate Cancer: Has the time come to reconsider structured population-based PSA screening for prostate cancer? 2019. Accessible at http://epad.uroweb.org/wp-content/uploads/EAU_policy-briefing_PSA.pdf (last accessed September 2020)
5 Europa Uomo. The real effects of prostate cancer treatment: EUPROMS First ever prostate patient-driven quality of life study. 2020. Accessible at https://www.europa-uomo.org/news/quality-of-life-worse-than-previously-thought-europa-uomo-reports/ (last accessed October 2020)